• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

2002 to 2022 Saw Increased Use of Complementary Health by U.S. Adults

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 7, 2024.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Feb. 7, 2024 -- Between 2002 and 2022, U.S. adults significantly increased use of complementary health approaches (CHAs), including for pain management, according to a research letter published online Jan. 25 in the Journal of the American Medical Association.

Richard L. Nahin, Ph.D., from the National Institutes of Health in Bethesda, Maryland, and colleagues used data from the 2002, 2012, and 2022 National Health Interview Survey to examine trends in CHA use (including acupuncture, chiropractic care, guided imagery and/or progressive muscle relaxation, massage, naturopathy, and yoga) among U.S. adults.

The researchers found that adults reporting use of any of the seven approaches increased significantly from 19.2 percent in 2002 to 36.7 percent in 2022. For each individual modality, trends were significant. The largest increase in use was seen for yoga (5.0 percent in 2002 to 15.8 percent in 2022). Meditation had the highest prevalence used by 17.3 percent of individuals in 2022. Acupuncture was increasingly covered by insurance, and use increased from 1.0 percent in 2002 to 2.2 percent in 2022. Among participants reporting use of any CHA, the percentage reporting use for pain management increased significantly for each modality and overall, from 42.3 percent in 2002 to 49.2 percent in 2022. Among modalities used for pain management, yoga showed the largest increase in use for pain management, while chiropractic care had the highest use.

"This shift in utilization coincides with increased pain prevalence nationally and may be attributable to several factors, including randomized clinical trials suggesting that some CHAs provide low to moderate levels of pain management, incorporation of CHAs into best practice pain management guidelines, and the need to mitigate unnecessary use of potentially harmful opioids through use of nonopioid interventions," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted February 2024

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.